Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders


MILWAUKEE, July 21, 2025 /PRNewswire/ -- The Ademi Firm is investigating ZimVie (NASDAQ: ZIMV) for possible breaches of fiduciary duty and other violations of law in its transaction with ARCHIMED.

Ademi & Fruchter Logo (PRNewsfoto/Ademi LLP)

Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.  There is no cost or obligation to you.

In the transaction, shareholders of ZimVie will receive $19.00 per share in cash or approximately $730 million in enterprise value. ZimVie insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for ZimVie by imposing a significant penalty if ZimVie accepts a competing bid. We are investigating the conduct of the ZimVie board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi & Fruchter LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ademi-firm-investigates-whether-zimvie-inc-is-obtaining-a-fair-price-for-its-public-shareholders-302509567.html

SOURCE Ademi LLP

Werbung

ZimVie Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für ZimVie nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.